Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Sep 14;29(9):1160–1167. doi: 10.1089/jwh.2019.7851

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright 2020, Mary Ann Liebert, Inc., publishers

PMC Copyright notice

FIG. 2. — CSS within each stage, stratified by sex and age. Within each stage, females age <45 had superior CSS to same age group males and both females and males of other (older) age strata. (A) Stage II: Within age strata, female CSS was superior to males, but it reached statistical significance only for patients age <45 (p < 0.0001). (B) Stage III: Within age strata, the female CSS superiority was statistically significant for patients age <45 (p = 0.01) and ≥60 years (p = 0.004). (C) Stage IV: Within age strata, female CSS was superior to males, but it did not achieve statistical significance in subgroup analysis within age strata. CSS, cancer-specific survival.

FIG. 2. — CSS within each stage, stratified by sex and age. Within each stage, females age <45 had superior CSS to same age group males and both females and males of other (older) age strata. (A) Stage II: Within age strata, female CSS was superior to males, but it reached statistical significance only for patients age <45 (p < 0.0001). (B) Stage III: Within age strata, the female CSS superiority was statistically significant for patients age <45 (p = 0.01) and ≥60 years (p = 0.004). (C) Stage IV: Within age strata, female CSS was superior to males, but it did not achieve statistical significance in subgroup analysis within age strata. CSS, cancer-specific survival.